monitoring patients on antipsychotics for obesity, diabetes, and dyslipidemia

You'll see more focus on monitoring patients on antipsychotics for obesity, diabetes, and dyslipidemia.

Both the older antipsychotics (Largactil, etc) and the newer "atypical" antipsychotics (Clozaril, Zyprexa, etc) can increase the risk of weight gain, diabetes, or changes in lipid levels.

Weight gain. Largactil, Clozaril, and Zyprexa seem to cause the most. It happens with other antipsychotics, but not as much.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote